PhRMA Recommends Against FDA Pregnancy Labeling Oversight Committee
Executive Summary
An FDA pregnancy labeling oversight committee should not be a priority in the agency's efforts to redesign Rx pregnancy labeling, the Pharmaceutical Research and Manufacturers of America said in June 30 comments regarding pregnancy labeling proposals being considered by FDA.